3.20
price down icon1.84%   -0.06
after-market 시간 외 거래: 3.16 -0.04 -1.25%
loading
전일 마감가:
$3.26
열려 있는:
$3.28
하루 거래량:
36,897
Relative Volume:
1.90
시가총액:
$26.29M
수익:
-
순이익/손실:
$-30.16M
주가수익비율:
-9.4118
EPS:
-0.34
순현금흐름:
$-39.49M
1주 성능:
+7.74%
1개월 성능:
+10.34%
6개월 성능:
-1.54%
1년 성능:
+630.09%
1일 변동 폭
Value
$3.09
$3.28
1주일 범위
Value
$2.84
$3.28
52주 변동 폭
Value
$0.326
$4.60

Dare Bioscience Inc Stock (DARE) Company Profile

Name
명칭
Dare Bioscience Inc
Name
전화
858-926-7655
Name
주소
3655 NOBEL DRIVE, SAN DIEGO, CA
Name
직원
23
Name
트위터
@DareBioscience
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
DARE's Discussions on Twitter

DARE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
DARE
Dare Bioscience Inc
3.20 26.29M 0 -30.16M -39.49M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Dare Bioscience Inc 주식(DARE)의 최신 뉴스

pulisher
01:45 AM

Brokers Offer Predictions for Daré Bioscience Q1 Earnings - Defense World

01:45 AM
pulisher
Jun 05, 2025

H.C. Wainwright maintains Buy rating on Dare Bioscience stock By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 04, 2025

Daré Bioscience and Rosy Wellness Announce Strategic - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

Daré Bioscience partners with Rosy Wellness for new women’s health cream - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Dare Bioscience (DARE) Joins Forces with Rosy Wellness for Product Campaign | DARE Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Daré Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market Daré’s DARE to PLAY Sildenafil Cream - Yahoo Finance

Jun 04, 2025
pulisher
May 21, 2025

Dare Bioscience secures additional NIAID funding for HPV treatment - MSN

May 21, 2025
pulisher
May 17, 2025

Q2 EPS Estimate for Daré Bioscience Increased by Analyst - Defense World

May 17, 2025
pulisher
May 16, 2025

Daré outlines expanded dual path strategy targeting $4.5B hormone therapy market while accelerating commercialization in Q4 2025 - MSN

May 16, 2025
pulisher
May 15, 2025

Daré Bioscience’s Earnings Call: Strategic Moves Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025
pulisher
May 14, 2025

Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 14, 2025
pulisher
May 14, 2025

Dare Bioscience Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Dare Bioscience (DARE) Expands Strategy to Enhance Value for Sta - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Dare Bioscience Inc (DARE) Q1 2025 Earnings Call Highlights: Strategic Expansions and Cost ... - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Daré Bioscience Expands Women’s Health Portfolio - TipRanks

May 14, 2025
pulisher
May 13, 2025

Earnings call transcript: Dare Bioscience Q1 2025 unveils new products and cost cuts By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Dare Bioscience Q1 2025 unveils new products and cost cuts - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Daré Bioscience Q1 2025 Financial Results and Company Update - TradingView

May 13, 2025
pulisher
May 13, 2025

Daré Bioscience Unveils Major Commercial Push: 4 Women's Health Products Coming to $4.5B Market by 2026 - Stock Titan

May 13, 2025
pulisher
May 11, 2025

Daré Bioscience (DARE) Expected to Announce Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates - Nasdaq

May 08, 2025
pulisher
May 07, 2025

Daré Bioscience, Inc. (NASDAQ:DARE) Shares Purchased by Renaissance Technologies LLC - Defense World

May 07, 2025
pulisher
May 06, 2025

Daré Bioscience to Host First Quarter 2025 Financial - GlobeNewswire

May 06, 2025
pulisher
May 06, 2025

Daré Bioscience Q1 Earnings: Women's Health Innovator to Share Latest Financial Results May 13 - Stock Titan

May 06, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Purchases 3,593 Shares of Daré Bioscience, Inc. (NASDAQ:DARE) - Defense World

May 04, 2025
pulisher
Apr 30, 2025

Daré Bioscience targets Q4 2025 for Sildenafil Cream launch via 503B compounding - MSN

Apr 30, 2025
pulisher
Apr 23, 2025

Daré Bioscience to Present at the Fierce Pharma Engage - GlobeNewswire

Apr 23, 2025
pulisher
Apr 23, 2025

Daré CEO Unveils Game-Changing Women's Health Pipeline: Sildenafil Cream Launch Timeline Confirmed - Stock Titan

Apr 23, 2025
pulisher
Apr 12, 2025

Daré Bioscience (NASDAQ:DARE) Share Price Crosses Below 200-Day Moving Average – Here’s What Happened - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Dare Bioscience granted extension by Nasdaq to regain compliance - Investing.com India

Apr 12, 2025
pulisher
Apr 07, 2025

Daré Bioscience to Present at the Jones Healthcare and - GlobeNewswire

Apr 07, 2025
pulisher
Apr 07, 2025

Daré's Game-Changing Strategy: Sildenafil Cream Heads to Prescription Market Earlier Than Expected - Stock Titan

Apr 07, 2025
pulisher
Apr 07, 2025

Daré Bioscience to Present at the Jones Healthcare and Technology Innovation Conference on Expanded Business Strategy Including Action to Make its Proprietary Sildenafil Cream Formulation Available via Prescription This Year - GlobeNewswire

Apr 07, 2025
pulisher
Apr 05, 2025

Daré Bioscience Q1 EPS Estimate Increased by HC Wainwright - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

Q1 EPS Estimate for Daré Bioscience Decreased by Analyst - Defense World

Apr 04, 2025
pulisher
Apr 04, 2025

HC Wainwright Forecasts Daré Bioscience FY2029 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 04, 2025

Short Interest in Daré Bioscience, Inc. (NASDAQ:DARE) Rises By 22.2% - Defense World

Apr 04, 2025
pulisher
Apr 02, 2025

Daré Bioscience (NASDAQ:DARE) Receives Buy Rating from HC Wainwright - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Daré Bioscience Earnings Call: Strategic Progress Amid Challenges - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Daré Bioscience (DARE) Anticipates Revenue Boost from Sildenafil Cream in 2025 - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

Dare Bioscience Inc (DARE) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Home

Apr 01, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Dare Bioscience Q4 2024 focuses on women’s health innovations - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Dare Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Daré Bioscience Reports Full Year 2024 Financial Results - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

DARE BIOSCIENCE Earnings Results: $DARE Reports Quarterly Earnings - Nasdaq

Mar 31, 2025
pulisher
Mar 31, 2025

Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Daré Bioscience Reveals New Revenue Strategy: Sildenafil Cream Launch Coming Q4 2025 - Stock Titan

Mar 31, 2025

Dare Bioscience Inc (DARE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
자본화:     |  볼륨(24시간):